Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

TerminatedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Phenylketonuria
Interventions
DRUG

Kuvan

20/mg/kg/day taken once daily or as otherwise prescribed by physician as standard care.

Trial Locations (4)

60614

Northwestern University/Children's Memorial Hospital, Chicago

63130

Washington University, St Louis

65211

University of Missouri, Columbia

97239

Oregon Health & Science University, Portland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioMarin Pharmaceutical

INDUSTRY

collaborator

University of Missouri-Columbia

OTHER

collaborator

Northwestern University

OTHER

collaborator

Oregon Health and Science University

OTHER

lead

Washington University School of Medicine

OTHER